France Fines J&J 25 Million Euros Over Painkiller Patch

999View
Dec 20, 2017

   Wochit
On Wednesday, France's competition authority fined U.S. healthcare group Johnson & Johnson 25 million euros , after it ruled the company had deliberately slowed market access to generic copies of its painkiller Durogesic. Durogesic is sold as a skin patch to control ongoing moderate to severe pain and is often prescribed in cancer cases. It contains fentanyl, an opioid which, if misused, can lead to death by overdose.


Report